Screener
Carlsmed, Inc. CARL EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Carlsmed, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Carlsmed, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:10 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001794546-26-000016
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Net loss attributable to common stockholders | $(10,510) | $(6,766) | $(19,206) | $(13,079) |
| Net loss | $(10,510) | $(6,766) | $(19,206) | $(12,495) |
| Other comprehensive loss: | ||||
| Unrealized loss on available-for-sale debt securities | (17) | — | (17) | — |
| Total other comprehensive loss | (17) | — | (17) | — |
| Total comprehensive loss | $(10,527) | $(6,766) | $(19,223) | $(12,495) |
| Net loss per share attributable to common stockholders, basic and diluted | $(0.39) | $(1.47) | $(0.71) | $(2.94) |
| Weighted-average number of common shares used to compute basic and diluted net loss per share | 27,190,765 | 4,589,717 | 27,003,868 | 4,445,384 |
Item 1. Financial Statements.
FAQ
- What is Carlsmed, Inc.'s EPS (diluted)?
- Carlsmed, Inc. (CARL) reported EPS (diluted) of -$0.39 in Q2 2026.
- How has Carlsmed, Inc.'s EPS (diluted) changed year-over-year?
- Carlsmed, Inc.'s EPS (diluted) increased by 73.5% year-over-year, from -$1.47 to -$0.39.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Carlsmed, Inc.'s eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude